Work

Supplemental Figure S8 from A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Figure S8. RhoA activity is insensitive to ketorolac treatment.

DOI: 10.1158/1078-0432.22456113.v1

Authors: Yuna Guo, S. Ray Kenney, Linda Cook, Sarah F. Adams, Teresa Rutledge, Elsa Romero, Tudor I. Oprea, Larry A. Sklar, Edward Bedrick, Charles L. Wiggins, Huining Kang, Lesley Lomo, Carolyn Y. Muller, Angela Wandinger-Ness, Laurie G. Hudson

Language: English

Topic: Inflammatory mediators and NSAID effects

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361911615

Cites:

Cited by:

Related to: 10